FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (3D Imaging Drug Design and Development LLC)

View source ↗

Summary

FDA approved Fluorodeoxyglucose F18 (FDG F-18) as an original radiopharmaceutical for PET imaging to assess metabolic activity in oncology, neurology, and cardi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cancer
• Epilepsy
• Ischemic Heart Disease

Drugs mentioned

• Fludeoxyglucose F18 (Fludeoxyglucose F18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18)